WF
BMY icon

WealthTrust Fairport’s Bristol-Myers Squibb BMY Stock Holding History

WealthTrust Fairport’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$138K Buy
2,888
+257
+10% +$12.8K 0.01% 177
2018
Q4 		$137K Sell
2,631
-202
-7% -$10.9K 0.01% 171
2018
Q3 		$176K Hold
2,833
– – 0.02% 167
2018
Q2 		$157K Sell
2,833
-665
-19% -$35.9K 0.02% 176
2018
Q1 		$221K Sell
3,498
-2,479
-41% -$159K 0.02% 149
2017
Q4 		$366K Sell
5,977
-400
-6% -$25K 0.04% 139
2017
Q3 		$406K Buy
6,377
+44
+0.7% +$2.57K 0.04% 126
2017
Q2 		$353K Hold
6,333
– – 0.04% 125
2017
Q1 		$344K Buy
6,333
+2,076
+49% +$114K 0.04% 123
2016
Q4 		$249K Sell
4,257
-5,499
-56% -$301K 0.03% 136
2016
Q3 		$526K Buy
9,756
+4,293
+79% +$276K 0.06% 102
2016
Q2 		$402K Sell
5,463
-989
-15% -$69.9K 0.05% 109
2016
Q1 		$412K Sell
6,452
-1,093
-14% -$68.9K 0.06% 109
2015
Q4 		$519K Sell
7,545
-2,061
-21% -$136K 0.07% 110
2015
Q3 		$569K Buy
9,606
+343
+4% +$21.8K 0.08% 100
2015
Q2 		$616K Sell
9,263
-2,127
-19% -$140K 0.08% 95
2015
Q1 		$735K Sell
11,390
-1,079
-9% -$67.5K 0.1% 97
2014
Q4 		$736K Buy
12,469
+7,468
+149% +$421K 0.1% 94
2014
Q3 		$256K Buy
5,001
+4,314
+628% +$215K 0.04% 107
2014
Q2 		$33K Hold
687
– – ﹤0.01% 175
2014
Q1 		$36K Buy
687
+20
+3% +$1.06K 0.01% 163
2013
Q4 		$35K Sell
667
-284
-30% -$14.5K 0.01% 150
2013
Q3 		$44K Buy
951
+771
+428% +$33.8K 0.01% 166
2013
Q2 		$8K Buy
+180
New +$7.82K ﹤0.01% 259

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

WealthTrust Fairport's BMY Position: Q1 2019 in Review

WealthTrust Fairport increased its Bristol-Myers Squibb (BMY) stake by 9.8% in Q1 2019, buying an estimated $12.8K and bringing the position to 2,888 shares worth $138K. The position accounts for 0.01% of the portfolio, ranked #177.

WealthTrust Fairport first reported a position in BMY in Q2 2013 and has held it in 24 quarters since. The position peaked at $736K in Q4 2014. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • WealthTrust Fairport held 2,888 shares of Bristol-Myers Squibb worth $138K as of Q1 2019.
  • WealthTrust Fairport bought 257 Bristol-Myers Squibb shares in Q1 2019, an estimated $12.8K.
  • Bristol-Myers Squibb made up 0.01% of WealthTrust Fairport's portfolio in Q1 2019, its #177 holding.
  • WealthTrust Fairport first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 24 quarters since.
  • WealthTrust Fairport's Bristol-Myers Squibb position peaked at $736K in Q4 2014.
  • 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on WealthTrust Fairport's 13F filing for Q1 2019, filed 15 May 2019.